There is a statistic I encountered several years ago that I have not been able to stop thinking about: since 1950, global chemical production has increased from approximately 1 million tons annually to over 400 million tons — a four-hundred-fold increase in a single human lifetime (UNEP, 2019). The vast majority of these chemicals were introduced into commerce, and into human bodies, without comprehensive safety testing. Of the roughly 85,000 synthetic chemicals registered for commercial use in the United States, fewer than 300 have been tested for safety by the Environmental Protection Agency (EPA, 2016).
This is not a failure of science. It is a failure of regulatory architecture. The Toxic Substances Control Act (TSCA) of 1976 — the primary federal law governing chemical safety — was structured around a presumption of innocence: chemicals already on the market were grandfathered as assumed safe, and the burden of proving harm fell on the EPA rather than the manufacturer. The 2016 Lautenberg Chemical Safety Act reformed some of these provisions, requiring the EPA to evaluate existing chemicals for safety, but the backlog is enormous and the pace of review glacial — the EPA evaluated only 40 chemicals in the six years following the reform (EPA, 2022).
The consequence is a vast, uncontrolled experiment in which hundreds of millions of people are chronically exposed to synthetic chemicals whose health effects are unknown, poorly characterized, or known and inadequately regulated.
The endocrine disruption paradigm
The most scientifically established category of environmental health concern involves endocrine-disrupting chemicals (EDCs) — synthetic compounds that interfere with the hormonal systems that regulate development, reproduction, metabolism, and immune function. The endocrine system operates at extraordinarily low concentrations — hormones exert their effects at parts-per-trillion levels — making it uniquely vulnerable to disruption by exogenous chemicals at doses far below those required to produce acute toxicity.
The concept of endocrine disruption was crystallized by Theo Colborn's landmark 1996 book Our Stolen Future, which synthesized evidence from wildlife biology, toxicology, and epidemiology to argue that synthetic chemicals were interfering with hormonal signaling in ways that produced subtle but consequential effects on reproduction, development, and health. The hypothesis was initially controversial but has since been validated by an enormous body of research. The Endocrine Society — the world's largest organization of endocrinologists — has issued two scientific statements (in 2009 and 2015) concluding that EDC exposure is a significant public health concern with strong mechanistic evidence of harm (Gore et al., 2015).
The key chemicals
Several classes of EDCs have particularly robust evidence of health effects:
Bisphenol A (BPA) and its replacements. BPA is a synthetic estrogen used in polycarbonate plastics, epoxy can linings, thermal receipt paper, and numerous consumer products. Over 90% of Americans have detectable BPA in their urine (Calafat et al., 2008). BPA has been associated with reproductive abnormalities, metabolic dysfunction, cardiovascular disease, and neurodevelopmental effects in hundreds of animal studies and a growing number of human epidemiological studies. The FDA banned BPA from baby bottles and sippy cups in 2012, but it remains legal in virtually all other applications. Many manufacturers have replaced BPA with structurally similar chemicals — BPS, BPF, BPAF — that emerging evidence suggests may be equally or more endocrine-active than the compound they replaced (Rochester & Bolden, 2015).
Phthalates. These plasticizers are ubiquitous — found in vinyl flooring, food packaging, personal care products, children's toys, medical devices, and pharmaceuticals. They are "anti-androgens" — chemicals that interfere with male reproductive hormone signaling. A study published in Environmental Health Perspectives analyzed phthalate exposure in pregnant women and found that higher maternal phthalate levels were associated with reduced anogenital distance in male infants — a marker of insufficient androgen exposure during fetal development (Swan et al., 2005). Subsequent research has linked phthalate exposure to reduced sperm quality, altered pubertal timing, metabolic syndrome, and thyroid dysfunction.
Per- and polyfluoroalkyl substances (PFAS). Termed "forever chemicals" because they do not break down in the environment, PFAS have been used since the 1940s in non-stick cookware, water-resistant clothing, food packaging, and firefighting foam. PFAS contaminate drinking water supplies serving an estimated 110 million Americans (Andrews & Naidenko, 2020). Health effects associated with PFAS exposure include immunosuppression (reduced antibody response to vaccination), thyroid disease, elevated cholesterol, liver damage, reproductive toxicity, and increased cancer risk — particularly kidney and testicular cancer (Fenton et al., 2021). The EPA established the first enforceable drinking water standards for PFAS in 2024, setting maximum contaminant levels at 4 parts per trillion for PFOA and PFOS — effectively acknowledging that no level of exposure is safe.
Pesticides. Organophosphate insecticides, which account for approximately 33% of global insecticide use, are acetylcholinesterase inhibitors — chemicals that interfere with the enzyme responsible for breaking down the neurotransmitter acetylcholine. Chronic low-level exposure has been associated with neurodevelopmental effects in children, including reduced IQ, attention deficits, and increased risk of autism spectrum disorder (Rauh et al., 2012). Agricultural workers experience the highest exposures, but residues on conventionally grown produce represent a significant route of exposure for the general population.
The timing hypothesis
One of the most important paradigm shifts in environmental health science has been the recognition that the timing of chemical exposure may be more important than the dose. Traditional toxicology operates on the principle "the dose makes the poison" — higher doses produce greater effects. But endocrine disruption does not follow this rule.
During critical windows of development — particularly prenatal development, early infancy, and puberty — the endocrine system is orchestrating complex developmental programs that are exquisitely sensitive to hormonal signals. Exposure to EDCs during these windows can produce effects at doses that would be inconsequential in adults, and the consequences may not manifest for years or decades.
The concept of the "developmental origins of disease" — formalized by David Barker and extended by numerous researchers — proposes that many chronic diseases of adulthood, including obesity, diabetes, cardiovascular disease, and certain cancers, have their origins in prenatal and early postnatal environmental exposures that alter developmental trajectories (Heindel et al., 2017). If this hypothesis is correct — and the evidence is increasingly persuasive — then the chemical exposures experienced by a pregnant woman may influence her grandchild's disease risk through epigenetic mechanisms that alter gene expression without changing the DNA sequence.
Animal studies have demonstrated precisely this kind of transgenerational effect. Exposure of pregnant rats to the fungicide vinclozolin produced reproductive abnormalities not only in the directly exposed offspring but in the third generation — great-grandchildren of the originally exposed animals — through epigenetic modifications that were transmitted through the germline (Anway et al., 2005). Whether similar transgenerational effects occur in humans remains an active area of investigation.
The mixture problem
Regulatory toxicology evaluates chemicals one at a time, at isolated doses, in controlled laboratory conditions. Humans are exposed to thousands of chemicals simultaneously, continuously, in complex and variable mixtures. The gap between regulatory testing and real-world exposure is enormous, and the concept of "mixture toxicity" — the possibility that chemicals produce greater effects in combination than any individual chemical produces alone — has emerged as one of the most important unsolved problems in environmental health science.
A study published in Environmental Health Perspectives tested the effects of combining 11 common environmental chemicals — including BPA, phthalates, pesticides, and heavy metals — at concentrations individually considered "safe" by regulatory standards. The mixture produced significant metabolic effects in laboratory animals that no individual chemical produced at its tested concentration (Christiansen et al., 2012). The regulatory framework assumes that chemicals below their individual no-observed-adverse-effect level (NOAEL) pose no risk. The evidence suggests this assumption is wrong.
The practical implication is that regulatory standards based on single-chemical testing may systematically underestimate the health risks of real-world exposures, in which humans are simultaneously exposed to hundreds of chemicals, many of which share common biological targets and may produce additive or synergistic effects.
The body burden
Biomonitoring studies — which measure chemical concentrations in blood, urine, and tissue samples — have demonstrated that virtually every person on earth carries a measurable burden of synthetic chemicals. The CDC's National Report on Human Exposure to Environmental Chemicals, the most comprehensive biomonitoring program in the world, has detected over 400 environmental chemicals in blood and urine samples from the US population (CDC, 2022).
These detections include flame retardants (in 97% of Americans), phthalates (in 99%), BPA (in 93%), PFAS (in 98%), pesticide metabolites (in 75%), heavy metals including lead and mercury (in virtually 100%), and polychlorinated biphenyls (PCBs, banned in 1979 but still detectable in 100% of adults due to environmental persistence and bioaccumulation) (CDC, 2022).
The health significance of these body burdens at population levels remains a subject of intense scientific debate. The chemicals are detectable, frequently at concentrations associated with health effects in animal studies. But establishing causal relationships between low-level chronic exposures and health outcomes in human populations is methodologically challenging: exposures are ubiquitous (making unexposed control groups impossible to find), confounded by socioeconomic and lifestyle factors, and may produce effects that are delayed, subtle, or expressed only in genetically susceptible individuals.
What you can do
Given the scale and complexity of environmental chemical exposure, it is important to be honest about what individual action can and cannot accomplish. No amount of personal vigilance can eliminate chemical exposure in a society that produces 400 million tons of synthetic chemicals annually. But evidence-based exposure reduction strategies can meaningfully decrease your body burden of the most well-characterized toxicants:
Eat whole, unprocessed foods. Ultra-processed foods are a significant source of chemical exposure — through packaging materials (BPA, phthalates, PFAS), processing equipment, and intentional additives. A study published in Environmental Health Perspectives found that participants who switched to a fresh-food diet for three days showed a 66% reduction in urinary BPA and a 55% reduction in the phthalate DEHP metabolite compared to their usual diet (Rudel et al., 2011).
Filter your drinking water. Activated carbon filters remove many organic contaminants, including chlorination byproducts, pesticides, and some PFAS. Reverse osmosis systems provide more comprehensive filtration, removing PFAS, heavy metals, and most synthetic chemicals.
Reduce plastic food contact. Do not microwave food in plastic containers (heat accelerates chemical migration). Use glass or stainless steel for food storage when practical. Avoid products labeled with recycling codes 3 (PVC/phthalates) and 7 (potential BPA).
Choose personal care products carefully. The Environmental Working Group's Skin Deep database evaluates the ingredients in over 90,000 personal care products, providing a practical tool for identifying products with lower chemical loads.
Ventilate your home. Indoor air concentrations of many chemicals — flame retardants, volatile organic compounds, formaldehyde — are typically 2-5 times higher than outdoor levels. Regular ventilation and the use of HEPA air purifiers can reduce indoor chemical exposure meaningfully.
Support regulatory reform. The most impactful interventions are structural: strengthening chemical safety testing requirements, holding manufacturers responsible for demonstrating safety before market entry, adequately funding the EPA's chemical evaluation program, and restricting the use of chemicals with strong evidence of endocrine disruption. Individual exposure reduction is valuable but cannot substitute for systemic change.
The chemical environment we live in is a vast, uncontrolled experiment that began seventy years ago and has never been paused. We are only beginning to understand the results.
References
- Andrews, D. Q., & Naidenko, O. V. (2020). Population-wide exposure to per- and polyfluoroalkyl substances from drinking water in the United States. Environmental Science & Technology Letters, 7(12), 931–936.
- Anway, M. D., et al. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science, 308(5727), 1466–1469.
- Calafat, A. M., et al. (2008). Exposure of the US population to bisphenol A and 4-tertiary-octylphenol. Environmental Health Perspectives, 116(1), 39–44.
- CDC. (2022). Fourth National Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention.
- Christiansen, S., et al. (2012). Synergistic disruption of external male sex organ development by mixtures of anti-androgenic chemicals. Environmental Health Perspectives, 120(12), 1751–1756.
- EPA. (2016). TSCA Chemical Substance Inventory. Environmental Protection Agency.
- EPA. (2022). TSCA Implementation Progress Report. Environmental Protection Agency.
- Fenton, S. E., et al. (2021). Per- and polyfluoroalkyl substance toxicity and human health review. Environmental Toxicology and Chemistry, 40(3), 606–630.
- Gore, A. C., et al. (2015). EDC-2: The Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews, 36(6), E1–E150.
- Heindel, J. J., et al. (2017). Developmental origins of health and disease. Reproductive Toxicology, 68, 62–84.
- Rauh, V. A., et al. (2012). Brain anomalies in children exposed prenatally to a common organophosphate pesticide. PNAS, 109(20), 7871–7876.
- Rochester, J. R., & Bolden, A. L. (2015). Bisphenol S and F: A systematic review and comparison of the hormonal activity of BPA substitutes. Environmental Health Perspectives, 123(7), 643–650.
- Rudel, R. A., et al. (2011). Food packaging and bisphenol A and bis(2-ethylhexyl) phthalate exposure. Environmental Health Perspectives, 119(7), 914–920.
- Swan, S. H., et al. (2005). Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives, 113(8), 1056–1061.
- UNEP. (2019). Global Chemicals Outlook II. United Nations Environment Programme.